3Mixtatin and MTA Vital Pulpotomy in Primary Molars
Trial statusNot yet recruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age4-8
SponsorCairo University
About this trial
The aim of the study is to evaluate clinical and radiographic success of using 3Mixtain versus mineral trioxide aggregate in pulpotomy of deeply carious Primary molars.
Eligibility criteria
Qualifiers
• Children 4-8 years old
Vital deeply carious primary molars.
No history of spontaneous pain, pathologic mobility, draining sinus tract, redness or swelling of the vestibule.
Normal gingival and periodontal condition, with no sensitivity to vestibular palpation, and no pain on percussion test.
Disqualifiers
• Uncooperative children to avoid time waste and attrition bias.
Unrestorable molars
Sign of radiolucency in periapical or furcation area
Widening of PDL space or loss of lamina dura continuity
Trial design
Treatments tested in this trial
- 3 mixtatin pulpotomy
- MTA pulpotomy
Treatment groups
50 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov